Correlation Between Apogee Therapeutics, and Shimmick Common

Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Shimmick Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Shimmick Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apogee Therapeutics, Common and Shimmick Common, you can compare the effects of market volatilities on Apogee Therapeutics, and Shimmick Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Shimmick Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Shimmick Common.

Diversification Opportunities for Apogee Therapeutics, and Shimmick Common

-0.33

Correlation Coefficient

Apogee Therapeutics,  Shimmick Common

Very good diversification

The 3 months correlation between Apogee and Shimmick is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Shimmick Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shimmick Common and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Shimmick Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shimmick Common has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Shimmick Common go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and Shimmick Common

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to generate 0.56 times more return on investment than Shimmick Common. However, Apogee Therapeutics, Common is 1.79 times less risky than Shimmick Common. It trades about 0.08 of its potential returns per unit of risk. Shimmick Common is currently generating about 0.0 per unit of risk. If you would invest  1,700  in Apogee Therapeutics, Common on October 4, 2024 and sell it today you would earn a total of  2,830  from holding Apogee Therapeutics, Common or generate 166.47% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	76.61%
Values	Daily Returns

Apogee Therapeutics, Common  vs.  Shimmick Common

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Shimmick Common

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Shimmick Common are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady forward indicators, Shimmick Common may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Apogee Therapeutics, and Shimmick Common

The main advantage of trading using opposite Apogee Therapeutics, and Shimmick Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Shimmick Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shimmick Common will offset losses from the drop in Shimmick Common's long position.

The idea behind Apogee Therapeutics, Common and Shimmick Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.